Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;47(2):107-14.
doi: 10.1053/j.seminhematol.2010.01.001.

CD20 as a target for therapeutic type I and II monoclonal antibodies

Stephen A Beers  1 , Claude H T Chan, Ruth R French, Mark S Cragg, Martin J Glennie
Affiliations
Review

CD20 as a target for therapeutic type I and II monoclonal antibodies

Stephen A Beers et al. Semin Hematol. 2010 Apr.

Abstract

The last decade has seen the monoclonal antibody (mAb), rituximab, transform clinical management of many non-Hodgkin lymphomas and more recently provide new opportunities for controlling autoimmune conditions, such as rheumatoid arthritis. Although not yet fully determined, the explanation for this success appears to lie with the inherent properties of its target, CD20, which allow rituximab to recruit potent cytotoxic effectors with unusual efficiency. In this review we detail the properties of CD20 that make it such an effective therapeutic target and describe how different mAbs change the membrane distribution and internalization of CD20 and have distinct modes of cytotoxic activity.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources